US Food and Drug Administration outlines new benzodiazepine warnings

The US Food and Drug Administration (FDA) has issued new guidance about the information that must be displayed on benzodiazepine medication. The requirements mean that information about dependence, overdose and withdrawal must be displayed on all such medications to help inform physicians and patients. The new regulations will apply to all benzodiazepine medications including Xanax and Valium.